Literature DB >> 27091956

Inappropriate prescription of antibiotics in pediatric practice: Analysis of the prescriptions in primary care.

Clémence Marc1,2, Bénédicte Vrignaud1, Karine Levieux1, Antoine Robine2, Christèle Gras-Le Guen1,3, Elise Launay3.   

Abstract

Misuse of antibiotics is largely responsible for the emergence of bacterial resistance. Children represent a subset of the population who frequently receive antibiotics. The objectives were to calculate the frequency of antibiotic prescriptions that do not comply with best practice recommendations in paediatrics primary care and to examine the thoughts and feelings of physicians and parents about antibiotic prescription and recommendations from the national health authorities. We included children admitted at the paediatric emergency room (PER) of the NANTES university hospital between June 2011 and October 2012 and who were under antibiotic drugs. Two independent experts evaluated the compliance with the national recommendations. Parents and general practitioner (GP) who prescribed the antibiotic before admission to PER were called to collect their thoughts and feeling about antibiotic prescription. The median age of the 88 included children was 2.8 years. The upper respiratory tract infection motivated the prescription of antibiotic in 59%. Seventy-six per cent of the prescriptions analysed were inappropriate, 72% of the antibiotics had a too broad spectrum, and one-third was not indicated. Ninety-one per cent of the interviewed parents thought that the antibiotic prescribed to their child was adequate. Among the 77 prescribing GP who were called, 33% agreed that they lacked time during consultation to explain to parents that no antibiotics were required. Antibiotic prescriptions were too often inadequate in this sample of children admitted in a French PER. Efforts have to be made with physicians and general public to optimize the antibiotic drug use.

Entities:  

Keywords:  Antibiotics; antibiotics stewardship; paediatrics; prescription; upper respiratory tract infections

Year:  2016        PMID: 27091956     DOI: 10.1177/1367493516643421

Source DB:  PubMed          Journal:  J Child Health Care        ISSN: 1367-4935            Impact factor:   1.979


  6 in total

Review 1.  Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Yizhong Wang; Xiaolu Li; Ting Ge; Yongmei Xiao; Yang Liao; Yun Cui; Yucai Zhang; Wenzhe Ho; Guangjun Yu; Ting Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

2.  A multifaceted approach to decrease inappropriate antibiotic use in a pediatric outpatient clinic.

Authors:  Jaffar A Al-Tawfiq; Amel H Alawami
Journal:  Ann Thorac Med       Date:  2017 Jan-Mar       Impact factor: 2.219

3.  Antibiotic prescribing for upper respiratory infections among children in rural China: a cross-sectional study of outpatient prescriptions.

Authors:  Zhitong Zhang; Yanhong Hu; Guanyang Zou; Mei Lin; Jun Zeng; Simin Deng; Rony Zachariah; John Walley; Joseph D Tucker; Xiaolin Wei
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

4.  Rational prescribing of antibiotics in children under 5 years with upper respiratory tract infections in Kintampo Municipal Hospital in Brong Ahafo Region of Ghana.

Authors:  Abdul-Nasiru Sumaila; Philip Teg-Nefaah Tabong
Journal:  BMC Res Notes       Date:  2018-07-04

5.  Telephone Consultation and Prescription in Pediatrics: Contributing Factors and Impact on Clinical Outcomes.

Authors:  Raymond N Haddad; Celine Sakr; Lydia Khabbaz; Hayat Azouri; Bassam Eid
Journal:  Front Pediatr       Date:  2020-01-15       Impact factor: 3.418

6.  Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections.

Authors:  Philipp Baumann; Gurli Baer; Jessica Bonhoeffer; Aline Fuchs; Verena Gotta; Ulrich Heininger; Nicole Ritz; Gabor Szinnai; Jan Bonhoeffer
Journal:  Front Pediatr       Date:  2017-08-28       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.